Exhibit 2.4
AMENDMENT TO AMR STOCK PURCHASE AGREEMENT
This Amendment to the Stock Purchase Agreement is dated as of
February 10, 2005 (this "Amendment"), by and among Laidlaw International, Inc.
("Parent"), Laidlaw Medical Holdings, Inc. ("Seller") and Emergency Medical
Services Corporation (formerly known as EMSC, Inc.) ("Purchaser"). Capitalized
terms used herein and not otherwise defined herein shall have the meanings
ascribed to them in the AMR Stock Purchase Agreement.
RECITALS
WHEREAS, Parent, Seller and Purchaser entered into that certain
Stock Purchase Agreement, dated as of December 6, 2004 (the "AMR Stock Purchase
Agreement"), pursuant to which Purchaser agreed to purchase 100% of the voting
securities of American Medical Response, Inc.;
WHEREAS, the parties to the AMR Stock Purchase Agreement currently
anticipate that the transactions contemplated by the AMR Stock Purchase
Agreement will be consummated after January 31, 2005;
WHEREAS, pursuant to Purchaser's request, Parent and Seller have
agreed to amend the AMR Stock Purchase Agreement to reflect that regardless of
the date of the consummation of the transactions, for certain purposes of the
AMR Stock Purchase Agreement, the "Closing Date" shall be deemed to be January
31, 2005, and to make certain other accommodations to Purchaser following the
Closing Date as described below.
NOW, THEREFORE, the parties agree as follows:
1. Amendment to Defined Term. The definition of "Agreement" in the AMR Stock
Purchase Agreement is hereby amended to include this Amendment.
2. Amendment to Section 1.02. Section 1.02 of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"Purchase Price. Subject to the terms and conditions of this Agreement, on
the Actual Closing Date, Purchaser shall pay Seller, by wire transfer of
immediately available funds, an amount equal to $565,000,000 (the "Purchase
Price") plus interest thereon for the period from January 31, 2005 (the "Closing
Date") to (and excluding) the Actual Closing Date (as defined below), at the
prime rate as quoted in the Money Rates Section of The Wall Street Journal (the
"Prime Rate"). The interest shall not be considered part of the Purchase Price,
but shall be paid at Closing. The Purchase Price shall be subject to adjustment
pursuant to Section 1.05 following the Closing."
3. Amendment to Section 1.03. Section 1.03 of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"Closing. The closing of the Share Purchase (the "Closing") will take
place at 10:00 a.m. local time on the fifth Business Day after satisfaction or
waiver (as permitted by this Agreement and applicable Law) by the appropriate
party of the conditions (excluding conditions that, by their terms, cannot be
satisfied until the Actual Closing Date, but subject to the fulfillment or
waiver of those conditions) set forth in Article VI (the "Actual Closing Date"),
unless another time or date is agreed to in writing by the parties hereto;
provided, however, Purchaser shall not be obligated to consummate the
Contemplated Transactions prior to the Outside Date if Purchaser would be
obligated to draw down the Bridge Facility (as defined in the BofA Financing
Commitment) or similar bridge financing under a Substitute Financing Commitment
rather than issue and sell Senior Subordinated Notes (as defined in the BofA
Financing Commitment) or similar securities contemplated by a Substitute
Financing Commitment to complete the financing contemplated by Section 4.08;
provided, further, that Purchaser shall be obligated to consummate the
Contemplated Transactions no later than the Actual Closing Date if all of the
conditions set forth in Section 6.02 (including, Section 6.02(n)) have been
satisfied or waived. The Closing shall be held at the offices of Kaye Scholer
LLP, 425 Park Avenue, New York, New York 10022, unless another place is agreed
to in writing by the parties hereto."
4. Amendment to Section 1.05 (a). The first sentence of Section 1.05(a) of
the AMR Stock Purchase Agreement is hereby amended and restated in its entirety
to read as follows:
"Within forty-five (45) days after the Actual Closing Date, Seller shall
prepare and deliver to Purchaser (i) an unaudited consolidated balance sheet of
the Acquired Company and the Subsidiaries dated as of the close of business on
the Closing Date (the "Closing Balance Sheet") showing the Net Worth of the
Acquired Company and the Subsidiaries at the Closing Date (the "Preliminary Net
Worth Amount") and (ii) a schedule (the "Closing Debt Schedule") of the amount
of Long Term Debt at the Closing Date (the "Preliminary Debt Amount")."
5. Amendment to Section 3.08(a). Section 3.08(a) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing the reference to "Closing"
with "Closing Date".
6. Amendment to Section 3.18 (e). Section 3.18(e) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing the reference to "Closing
Date" with "Actual Closing Date".
7. Amendment to Section 5.02(b). Section 5.02(b) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
8. Amendment to Section 5.05(a). Section 5.05(a) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
2
9. Amendment to Section 5.06. Section 5.06 of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date". In addition, Section 5.06(b) is further
amended and restated in its entirety as follows:
"(b) For a period of five years from and after the Actual Closing Date,
Purchaser shall cause the Acquired Company and the Subsidiaries to procure and
maintain in effect with respect to all periods prior to the Actual Closing Date,
directors' and officers' liability insurance (or Purchaser shall procure a
"tail" or "extended reporting period" policy) covering those present and former
officers and directors of the Acquired Company and the Subsidiaries who are
currently covered by directors' and officers' liability insurance policies on
terms not materially less favorable in the aggregate than the terms of such
current insurance coverage; provided, however, that if any Claim is asserted or
made within such five-year period, such insurance shall be continued in respect
of such Claim until the final disposition thereof; and, provided, further, that
Purchaser shall only be obligated to maintain such coverage (which shall be in
the form of a single policy which need not exceed $25,000,000, and which shall
cover (i) the present and former officers and directors of the Acquired Company
and the Subsidiaries and EmCare Holdings Inc. and its subsidiaries and (ii)
Parent and Seller in the event Parent and Seller are named as co-defendants in a
Claim asserted against D&O Indemnitees, the Acquired Company and the
Subsidiaries and/or EmCare Holdings Inc. and its subsidiaries) as may be
obtained for a cost no greater than $800,000, in the aggregate, with respect to
the coverages contemplated pursuant to this Section 5.06(b) and Section 5.06(b)
of the AMR Stock Purchase Agreement."
10. Amendment to Section 5.07(a). The second sentence of Section 5.07(a) of
the AMR Stock Purchase Agreement is hereby amended and restated in its entirety
to read as follows:
"Within two (2) Business Days of the Actual Closing Date, Seller shall
provide Purchaser with an updated Exhibit 5.07, which updated exhibit will
reflect any additional letters of credit provided by the Acquired Company and
the Subsidiaries between the date of this Agreement and the Actual Closing Date
for the purpose of collateralizing certain insurance obligations of, and
pursuant to Contracts entered into by, the Acquired Company and the Subsidiaries
(such additional letters of credit, the "Additional Letters of Credit" and
together with the Existing Letters of Credit, the "Letters of Credit")."
11. Amendment to Section 5.08. Section 5.08 of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"Intercompany Accounts. Immediately prior to the Closing, (a) all
intercompany accounts payable as of the Closing Date owing to Seller or its
Affiliates (other than the Acquired Company or any Subsidiary) by the Acquired
Company or any Subsidiary, and (b) all intercompany accounts payable as of the
Closing Date owing by Seller or its Affiliates (other than the Acquired Company
or any Subsidiary) to the Acquired Company or any Subsidiary shall be forgiven,
discharged, released, cancelled (including by way of capital contribution or
dividend) or paid, in each case as determined by Seller in its sole discretion,
except for any obligations and rights of Seller and its Affiliates (including,
the Acquired Company) under the Risk Financing Program Agreements. All such
intercompany accounts shall be deemed to have
3
been settled as of the Closing Date." It is the intention of the parties that
there be no intercompany accounts created after the Closing Date except as
specifically contemplated by Paragraph 35 of this Amendment or pursuant to the
terms of the Risk Financing Program Agreements.
12. Amendment to Section 5.09(a). Section 5.09(a) of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"(a) Exhibit 5.09 attached hereto sets forth (i) the surety or performance
bonds posted by Seller or its Affiliates for the benefit of the Business and as
required pursuant to Contracts entered into by the Acquired Company or a
Subsidiary (the "Existing Performance Bonds"); (ii) the issuer of each
Performance Bond; (iii) the beneficiary of each Performance Bond; and (iv) the
premium (the "Premium") paid by Seller or its Affiliates for each Performance
Bond to the issuer thereof. On the Actual Closing Date, Seller or Parent shall
provide to Purchaser an updated Exhibit 5.09, which updated exhibit will reflect
any additional surety or performance bonds posted by Seller or its Affiliates
between the date of this Agreement and the Closing Date for the benefit of the
Business and as required pursuant to Contracts entered into by the Acquired
Company or a Subsidiary, together with the information specified in (ii) - (iv)
above (such additional surety and performance bonds, the "Additional Performance
Bonds" and together with the Existing Performance Bonds, the "Performance
Bonds"). With respect to the Performance Bonds issued by Bond Safeguard or
Western, on the Actual Closing Date, the Acquired Company shall deliver to Bond
Safeguard or Western, as applicable, an indemnification agreement with respect
to the Performance Bonds issued by such issuer as of the Closing Date. With
respect to the Performance Bonds issued as of the Closing Date by an issuer
other than Bond Safeguard or Western (such issuers being referred to herein as
the "Alternative Issuers"), Purchaser agrees to use its commercially reasonable
efforts to (A) cause the Acquired Company or one or more of the Acquired
Company's Subsidiaries to obtain and post surety bonds in full substitution for
the Performance Bonds issued by such Alternative Issuers (the "Substitute
Bonds") within ninety (90) days after the Closing Date; and (B) cause the
beneficiary of the Performance Bonds issued by such Alternative Issuers to
return the original Performance Bonds to Parent and provide a release letter to
Parent regarding each such Performance Bond from the beneficiary, and Seller and
Parent hereby agree to cooperate in all respects with Purchaser in connection
therewith."
13. Amendment to Section 5.09(b). The phrase "at the time of closing" in the
sixth sentence of Section 5.09(b) of the AMR Stock Purchase Agreement shall be
deleted and replaced with "on the Closing Date".
14. Amendment to Section 5.09. Section 5.09(c) of the AMR Stock Purchase
Agreement is hereby amended and restated as follows and a new Section 5.09(d) is
added as follows:
"(c) With respect to any performance bonds posted by Seller or its
Affiliates for the benefit of the Business after the Closing Date which are not
Performance Bonds ("New Performance Bonds"), Purchaser agrees to use its
commercially reasonable efforts to cause the
4
Acquired Company or one or more of the Acquired Company's Subsidiaries to
provide a replacement bond and obtain a release of the New Performance Bonds
within ninety (90) days of the Actual Closing Date and Seller and Parent hereby
agree to cooperate in all reasonable respects with Purchaser in connection
therewith. Any collateral associated with New Performance Bonds is the property
and asset of Parent and shall not be provided to Purchaser at Closing.
(d) Purchaser shall indemnify and hold harmless Seller and its Affiliates
from and after the Closing Date for any Damages arising out of or relating to
any Performance Bonds and New Performance Bonds."
15. Amendment to Section 5.10. Section 5.10 of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"Resignations of Directors. Except as otherwise specifically directed by
Purchaser, each director of the Acquired Company or any Subsidiary as of the
Actual Closing Date shall resign as a director of the Acquired Company and any
such Subsidiaries and such resignations shall be delivered to Purchaser at
Closing."
16. Amendment to Section 5.12. Section 5.12 of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
17. Amendment to Section 5.13. Section 5.13 of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
18. Amendment to Section 6.01. The first clause of Section 6.01 of the AMR
Stock Purchase Agreement is hereby amended and restated in its entirety to read
as follows:
"Conditions to Obligations of Seller. The obligations of Seller to
consummate the Contemplated Transactions shall be subject to the satisfaction or
waiver at or prior to the Closing (unless as otherwise specifically contemplated
by this Agreement) of each of the following conditions:"
19. Amendment to Section 6.01(a). Section 6.01(a) of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"(a) Purchaser shall have performed and complied in all material respects
with all agreements and covenants required to be performed and complied with by
Purchaser under this Agreement at or prior to the Closing (except as otherwise
specifically contemplated by this Agreement)."
5
20. Amendment to Section 6.01(b). Section 6.01(b) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing the reference to "Closing
Date" with "Actual Closing Date".
21. Amendment to Section 6.01. Section 6.01 of the AMR Stock Purchase
Agreement is hereby amended to insert the following new subsection (j) at the
end thereof:
"(j) Any and all loans, premium costs for third party insurance allocated
to the Acquired Company consistent with past practice and interest accrued from
the Closing Date through to the Actual Closing Date owing to Parent or Seller by
Purchaser or Acquired Company or Subsidiaries shall be paid to Parent or Seller
prior to Closing or at Closing, provided, that such amount was invoiced to the
Acquired Company at least two (2) Business Days prior to the Closing Date."
22. Amendment to Section 6.02. The first clause of Section 6.02 of the AMR
Stock Purchase Agreement is hereby amended and restated in its entirety as
follows:
"Conditions to Obligations of Purchaser. The obligations of Purchaser to
consummate the Contemplated Transactions shall be subject to the satisfaction or
waiver at or prior to the Closing (unless as otherwise specifically contemplated
by this Agreement) of each of the following conditions:"
23. Amendment to Section 6.02(a). Section 6.02(a) of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety as follows:
"(a) Seller shall have performed and complied in all material respects
with all agreements and covenants required to be performed and complied with by
Seller under this Agreement at or prior to the Closing (except as otherwise
specifically contemplated by this Agreement)."
24. Amendment to Section 6.02(b). Section 6.02(b) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
25. Amendment to Section 8.01(a). Section 8.01(a) of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing the reference to "Closing
Date" with "Actual Closing Date".
26. Amendment to Section 8.02. Section 8.02 of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
6
27. Amendment to Section 8.03. Section 8.03 of the AMR Stock Purchase
Agreement is hereby amended by deleting and replacing all references to "Closing
Date" with "Actual Closing Date".
28. Amendment to Section 8.04(f)(i). The first sentence of Section 8.04(f)(i)
of the AMR Stock Purchase Agreement is hereby amended and restated in its
entirety to read as follows:
"(i) If such Claim relates to the Release of a Hazardous Substance at, on
or under the real property that the Acquired Company or any Subsidiary currently
or formerly owned or leased, the necessity for any investigation or remediation
("Corrective Action") shall be determined pursuant to the Environmental Laws in
effect on the Closing Date."
29. Amendment to Section 8.05(e). The last sentence of Section 8.05(e) of the
AMR Stock Purchase Agreement is hereby amended and restated in its entirety to
read as follows:
"For properties on which no Phase I assessment is performed prior to the
Closing Date, this Section 8.05 shall not apply. For the purposes of this
Section 8.05, the environmental reports, dated December 17, 2004, prepared by
Summit Environmental Systems with respect to the Inspection Properties in
Whittier, California and Los Angeles, California, and the environmental report,
dated December 7, 2004, prepared by Water Restoration, Inc. with respect to the
Inspection Property in Miami, Florida, in all cases including all attachments,
shall be designated as Phase I assessments with respect to the Inspection
Properties performed prior to the Closing Date."
30. Amendments to Section 8.06(f).
The first clause in subsection (e) of Section 8.06(f) of the AMR Stock
Purchase Agreement is hereby amended and restated in its entirety to read as
follows:
"(e) the representations and warranties of Seller contained in Section
3.10 (solely with respect to health care Laws), Section 3.11 (solely with
respect to health care Laws) and Section 3.22, to the extent any Claims under
such sections arise out of matters occurring after May 15, 2002, but prior to
the Closing Date, shall survive until three (3) years following the Closing
Date;"
31. Amendment to Section 8.07. The first sentence of Section 8.07 of the AMR
Stock Purchase Agreement is hereby amended and restated in its entirety to read
as follows:
"Exclusivity of Indemnification Remedy. Except for (a) fraud, (b)
agreements to be performed by the parties from and after the Actual Closing
Date, (c) covenants of the parties pursuant to Sections 5.02(b), 5.02(c), 5.06,
5.07, 5.08, 5.09, 5.14 (with respect to any Contracts entered into pursuant to
Section 5.14), 5.16, 5.18, 5.19, 5.22 and 5.23 or (d) any equitable relief,
7
including injunctive relief or specific performance, to which any party hereto
may be entitled, from and after the Actual Closing Date, the indemnification for
Damages provided in this Article VIII shall be the sole and exclusive remedy of
any party hereto with respect to this Agreement, any Other Seller Document or
any Other Purchaser Document."
32. Amendment to Section 9.01. The following defined terms in Section 9.01 of
the AMR Stock Purchase Agreement are hereby amended and restated in their
entirety to read as follows:
"Closing Date" has the meaning specified in Section 1.02.
"Post-Closing Tax Period" means any Tax Period beginning after the Actual
Closing Date and that portion of any Straddle Period beginning after the Actual
Closing Date.
"Pre-Closing Tax Period" means any Tax Period ending on or before the
Actual Closing Date and that portion of any Straddle Period ending on the Actual
Closing Date.
"Straddle Period" means any Tax Period that includes but does not end on
the Actual Closing Date.
33. Cash Management. Parent and Seller shall cause the Acquired Company and
the Subsidiaries to refrain from distributing any cash or assets to Parent or
Seller or their Affiliates after January 31, 2005.
34. Waiver of Section 5.01. The daily management of cash, payables and
receivables by the Acquired Company from the Closing Date to the Actual Closing
Date shall be subject to the provisions of Paragraph 33 of this Amendment, and
shall not be subject to the covenants under Section 5.01.
35. Loans. To the extent the Acquired Company requires cash for the period
from the Closing Date to the Actual Closing Date, Seller and Parent may lend
such cash to the Acquired Company, which loan shall bear interest at the Prime
Rate and shall be repaid as soon as practicable, but in all events no later than
the Closing or, if such amount is not invoiced, within two (2) Business Days
after receipt of such invoice. In addition, any amounts referenced in Section
6.01(j) that are not payable because they were not invoiced at least two (2)
Business Days prior to the Closing Date shall be payable within two (2) Business
Days after invoice.
36. Amendment to Addendum to Risk Financing Program Agreement. Purchaser
acknowledges that Seller and the Acquired Company have amended that certain
Addendum to the American Medical Response, Inc. Risk Financing Program Agreement
for fiscal 2005 as set forth on Exhibit A hereto and hereby consents to such
amendment.
8
37. Certain Payments. In satisfaction of its obligations pursuant to Section
5.16 of the AMR Stock Purchase Agreement, Seller hereby instructs Purchaser to
pay to the Acquired Company on behalf of and for the benefit of Parent the
amount of $14,311,000, which amount represents the aggregate amount owed by
Seller to any employees of the Acquired Company or any Subsidiary as a result of
the consummation of the Contemplated Transactions, including any "sale bonus,"
"change in control" payment or similar payment, plus Medicare tax payments of
1.45%. Seller represents such amount constitutes all amounts owing by Seller to
any employees of the Acquired Company or any Subsidiary as a result of the
consummation of the Contemplated Transactions, including any "sale bonus,"
"change in control" payment or similar payment, plus Medicare tax payments of
1.45%. Purchaser hereby agrees to (i) cause the Acquired Company to withhold and
pay over any required income tax and employment tax withholdings on such
payments; (ii) cause the Acquired Company to pay to the employees listed on
Exhibit B attached hereto on behalf of and for the benefit of Parent the amounts
set forth on Exhibit B promptly following the Closing; and (iii) use its
commercially reasonable efforts to cause such employees to sign a release in the
form of Exhibit C attached hereto in favor and for the benefit of Seller.
38. Amendment to Section 5.22. Section 5.22 of the AMR Stock Purchase
Agreement is hereby amended and restated in its entirety to read as follows:
"5.22 GE Master Lease. The Acquired Company is a party to that certain
Master Lease Agreement (the "GE Master Lease"), dated as of August 17, 2001,
with General Electric Credit Corporation (the "Lessor"), and is entering into a
Second Modification Agreement and Guaranty Release of the GE Master Lease (the
"Second Modification" and, the GE Master Lease as amended by the Second
Modification, the "Amended GE Master Lease") concurrently with the Closing.
Seller, Parent and Purchaser agree as follows:
(a) At or prior to the Closing, Parent will deliver to Lessor the Letter
of Credit (as such term is defined in paragraph (k) of the Second Modification
and referred to herein as the "GE Letter of Credit");
(b) At or prior to the Closing, Seller shall pay to Lessor the amendment
fee and all other amounts required to be paid pursuant to paragraph 4(f) of the
Second Modification;
(c) Seller shall reimburse the Acquired Company for all amounts required
to be paid by it pursuant to paragraph 5 of the Second Modification, provided,
that Seller shall reimburse such amounts arising in connection with enforcement
only as enforcement relates to the obligation in Section 18(d) of the Amended GE
Master Lease;
(d) Except as provided specifically in Sections 5.22(a), (b) and (c),
Parent and Seller shall have no liability with respect to any provisions of the
Amended GE Master Lease;
(e) Purchaser shall use its commercially reasonable efforts to cause the
Lessor to surrender the GE Letter of Credit to Parent (or to the Acquired
Company for delivery to Parent) in accordance with the provisions of Section
18(d) of the Amended GE Master Lease;
(f) Purchaser shall indemnify and hold harmless Parent from and after the
Actual Closing Date from any Damages arising out of or relating to the GE Letter
of Credit, but specifically
9
excluding any costs relating to obtaining or maintaining the GE Letter of Credit
as provided under Section 18(d) of the Amended GE Master Lease; and
(g) Purchaser shall not renew or extend the term of, or add additional
equipment under, the Amended GE Master Lease unless Lessor has surrendered the
GE Letter of Credit to Parent (or to the Acquired Company for delivery to
Parent) to be canceled."
39. New Section 5.24. A new Section 5.24 is hereby added to the Agreement, to
read in its entirety as follows:
"5.24 Brockton Mortgage. AMR Brockton, L.L.C., a Subsidiary of the
Acquired Company, as successor-in-interest to Industrial Boulevard LLC, has a
promissory note outstanding in the original principal amount of $2.45 million
(the "Brockton Note"), secured by a Mortgage, Deed of Trust and Security
Agreement dated as of September 28, 1998 (together with related documents, the
"Mortgage"). Seller has not obtained the Consent of the third parties required
under or otherwise necessary to avoid any breach or default under the Brockton
Note and the Mortgage upon consummation of the Contemplated Transactions.
Accordingly, Seller and Purchaser agree as follows:
(a) Prior to the Actual Closing Date, Seller shall cause the Acquired
Company to transfer to Seller all of the outstanding membership interests in AMR
Brockton, L.L.C. (the "Brockton Interests").
(b) The Purchase Price shall be reduced by $2,167,961.66, being the amount
of Long Term Debt at the Closing Date represented by the Brockton Note.
(c) Following the Closing, Seller and Purchaser will cooperate and use
commercially reasonable efforts to obtain any Consent of third parties necessary
to transfer the Brockton Interests to American Medical Response of
Massachusetts, Inc. ("AMR Mass"), and permitting AMR Brockton, L.L.C. to be a
guarantor under the Purchaser's debt facilities, without any breach or default
under the Brockton Note or the Mortgage, provided, that neither Seller nor
Purchaser shall be required to make any payment to any third party to secure any
such Consent and Purchaser shall not be required to agree to any significant
amendment to or modification of the Brockton Note or the Mortgage. Promptly
following receipt of all such Consents (assuming such Consents are obtained),
Seller shall transfer to AMR Mass the Brockton Interests, without payment to or
from either party; provided, that if Seller, in its sole discretion, elects to
prepay the Brockton Note and obtain a release of the Mortgage in lieu of
obtaining such Consents to the transfer of the Brockton Interests (including the
Brockton Note, the Mortgage and the related property), then, upon the transfer
of the Brockton Interests to AMR Mass, Purchaser hereby agrees to pay to Seller
on the day of such transfer (or, if later, the fourth Business Day after notice
to Purchaser of the amount payable) an amount in cash equal to the principal
amount of the Brockton Note outstanding when it was prepaid, which amount shall
be wired to the same bank account Parent identified to Purchaser for payment of
the Purchase Price at Closing.
(d) For the avoidance of doubt, the Brockton Note shall not be included in
the Preliminary Debt Amount or the Final Debt Amount.
10
40. Counterparts. This Amendment may be executed in one or more counterparts
(including by means of facsimile signature pages), each of which shall be deemed
an original, but all of which together shall constitute a single instrument.
41. Applicable Law. This Amendment shall be governed by and construed in
accordance with the laws of the State of New York without regard to conflicts of
laws principles.
42. No Further Effect. This Amendment is limited by its terms and does not
and shall not serve to amend any provision of the AMR Stock Purchase Agreement
except as expressly provided for in this Amendment. The AMR Stock Purchase
Agreement, as amended by this Amendment, is hereby ratified and confirmed and
shall continue in full force and effect.
[SIGNATURE PAGE TO FOLLOW]
11
IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment
as of the date first above written.
EMERGENCY MEDICAL SERVICES CORPORATION
By: /s/ Robert M. Le Blanc
------------------------------------
Name: Robert M. Le Blanc
Title: President
LAIDLAW INTERNATIONAL, INC.
By: /s/ Kevin E. Benson
------------------------------------
Name: Kevin E. Benson
Title: President and Chief Executive Officer
LAIDLAW MEDICAL HOLDINGS, INC.
By: /s/ Kevin E. Benson
------------------------------------
Name: Kevin E. Benson
Title: President and Secretary
[Signature Page to EmCare Amendment]
EXHIBIT A
AMENDMENT NO. 1 TO ADDENDUM TO
AMERICAN MEDICAL RESPONSE, INC.
RISK FINANCING PROGRAM
FISCAL 2004
(9/1/03 TO 8/31/04)
1. This Amendment No. 1 to the Addendum is made as of the 8th day of
February, 2005 (the "Amendment") by and between Laidlaw International,
Inc. ("LII"), a Delaware corporation, and American Medical Response, Inc.,
a Delaware corporation and an indirect wholly owned subsidiary of LII, and
each of its subsidiaries (collectively, "AMR"). Capitalized terms used
herein and not otherwise defined shall have the meanings ascribed to them
in the Addendum to American Medical Response, Inc. Risk Financing Program
Agreement Fiscal 2004 dated as of September 1, 2004, by and among LII and
AMR (the "Addendum").
2. Amendment to Section 5. Section 5 of the Addendum is hereby amended and
restated in its entirety as follows:
"Premiums to be Paid by AMR. In consideration of the fronting and
coverages under the Group Policies provided to AMR, AMR agrees to the
following premium reimbursement terms:
AMR will pay to LII on the payment schedule set forth below $4,956,690 to
purchase the following coverages and services:
Coverage Premium Amount
- -------- ------------------------
Fronting fees and taxes $1,323,933
Auto Liability $1,147,500
General Liability $ 83,997
Workers Compensation $ 595,000
Excess Casualty $ 895,564
Excess Casualty $ 198,418
Excess Casualty $ 29,052
Excess Casualty $ 34,723
Property $ 171,715
Boiler $ 9,070
Crime $ 47,467
Fiduciary $ 62,509
D&O Paid with management fee
USTs $ 10,995
Brokerage and other charges $ 346,747
Total = $4,956,690
The premium charges of $4,956,690 shall be paid by AMR to LII on a monthly
basis, commencing on 9/1/04, in twelve monthly installments of $413,075.50
each. All policy premium payments payable by AMR through February 1, 2005
have been paid to LII."
3. Counterparts. This Amendment may be executed in any number of counterparts
(including by means of facsimile signature pages), each of which shall be
considered an original, but all of which shall constitute one and the same
instrument.
4. Applicable Law. This Amendment shall be governed by and construed in
accordance with the laws of the State of Delaware without regard to
conflicts of laws principles.
5. No Further Effect. This Amendment is limited by its terms and does not and
shall not serve to amend any provision of the Addendum except as expressly
provided for in this Amendment. The Addendum, as amended by this
Amendment, is hereby ratified and confirmed and shall continue in full
force and effect.
[Signature page to follow]
IN WITNESS WHEREOF, the parties hereof have duly executed this Amendment
as of the date first written above.
AMERICAN MEDICAL RESPONSE, INC. LAIDLAW INTERNATIONAL, INC.
By: /s/ Randy Owen By: /s/ Douglas A. Carty
---------------------------- ------------------------------------
Name: Randy Owen Name: Douglas A. Carty
Title: Chief Financial Officer Title: Senior Vice President and Chief
Financial Officer
Exhibit B
INDIVIDUALS: PAYMENT AMOUNT:
- ----------- ---------------
Bill Sanger $ 12,691,032.45
Randy Owen $ 200,363.35
David Mintz $ 114,493.34
Lou Meyer $ 114,493.34
Robert LaTorraca $ 114,493.34
Steve Murphy $ 80,431.57
William Tara $ 80,431.57
Glenn Leland $ 80,431.57
Tom Sutherland $ 78,714.17
David Skeen $ 65,547.44
Kim Norman $ 65,547.44
Ron Thackery $ 65,547.44
Jason Standifird $ 62,685.10
Roylene Rhodes $ 50,377.07
Mark Bruning $ 41,503.84
Patricia Frachetti $ 41,503.84
Randy Skomsvold $ 41,503.84
Robert Garner $ 41,503.84
Robert Zuckswert $ 41,503.84
Alyse Hutchinson $ 34,348.00
EXHIBIT C
RELEASE
FOR VALUE RECEIVED, ____________ (the "Named Individual") does hereby,
effective as of the Actual Closing Date (as defined in that certain Stock
Purchase Agreement dated as of December 6, 2004, as amended on February __, 2005
(the "Stock Purchase Agreement"), by and among Laidlaw International, Inc.
("Parent"), Laidlaw Medical Holdings, Inc. ("Seller") and Emergency Medical
Services Corporation (f/k/a EMSC, Inc.)), remise, release and forever discharge
Parent, Seller and their respective affiliates, directors, officers, employees,
representatives, attorneys, agents, stockholders, members, successors, assigns,
legal and personal representatives, and each of every one of them (collectively,
the "Releases"), of and from all claims and demands and all manner of actions,
causes of action, suits, proceedings, debts, liabilities, obligations, accounts,
contracts, and damages whatsoever, in law or equity, for amounts payable to such
Named Individual (i) as a result of the consummation of the Contemplated
Transactions, including any "sale bonus," "change in control" payment or similar
payment; (ii) pursuant to the Laidlaw International, Inc. Value Appreciation
Rights Plan; or (iii) pursuant to any employment agreement with the Named
Individual.
All capitalized terms used herein that are not otherwise defined shall
have the meanings assigned such terms in the Stock Purchase Agreement.
IN WITNESS WHEREOF, the Named Individual has executed this Release as of
this ___ day of February, 2005.
________________________________
Name:
AGREED TO AND ACCEPTED
this __ day of February, 2005.
LAIDLAW INTERNATIONAL, INC.
By: ____________________________________
Name:
Title:
LAIDLAW MEDICAL HOLDINGS, INC.
By: ____________________________________
Name:
Title: